HERITABLE HIGH-FREQUENCY MODULATION OF ANTIGEN EXPRESSION IN NEOPLASTIC-CELLS EXPOSED TO 5-AZA-2'-DEOXYCYTIDINE OR HYDROXYUREA - ANALYSIS AND IMPLICATIONS
- 1 May 1988
- journal article
- research article
- Vol. 48 (9) , 2440-2445
Abstract
A study was undertaken to determine the ability of the DNA hypomethylating drug 5-aza-2''-deoxycytidine (5-azadCyd) to induce antigen expression in a high proportion of treated tumor cells and to evaluate if this effect could be mimicked by the drug hydroxyurea (HU) which is a genomic DNA hypermethylating agent. Induction of heritable changes in gene expression by 5-azacytidine or the 2''-deoxy analogue (5-azadCyd), at least in some cases, may not be necessarily due to their hypomethylating properties, but to some other induced high frequency genetic change which occurs when DNA synthesis or repair is pertubed. A comparison of 5-azadCyd and HU effects on human and murine tumors was chosen for this study. The phenotypic properties examined with the above treatments were (a) induction of a Mr 110,000 antigen, detected with M111 antibody, in a variant subpopulation (SMeLus7) of human melanoma cells which fail to maximally express this antigen (M111). The parent cell line, MeWo, and other MeWo-derived variant cell cell lines do not demonstrate a similarly inducible phenotype; and (b) induction of class I major histocompatibility complex antigens in a population of mouse mammary adenocarcinoma cells which normally fail to express these antigens. The results showed that 5-azadCyd was effective in inducing antigen expression in both systems whereas HU was effective (and equally so) only in the human melanoma cell line system. In these treatments 5-azadCyd was demonstrated to transiently hypomethylate the same human melanoma cell line whereas HU hypermethylated genomic cytosines. The results suggest that some of the reported effects of 5-azacytidine or 5-azadCyd in inducing very high frequency heritable phenotypic alterations may not necessarily be related to the drugs'' ability to cause DNA hypomethylation. The implications of these results are discussed in terms of the use of 5-azacytidine or 5-azadCyd and the effects of chemotherapy on tumor progression and metastasis.This publication has 26 references indexed in Scilit:
- SINGLE-STEP SELECTION OF UNIQUE HUMAN-MELANOMA VARIANTS DISPLAYING UNUSUALLY AGGRESSIVE METASTATIC BEHAVIOR IN NUDE ATHYMIC MICE1984
- Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea.Molecular and Cellular Biology, 1983
- Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting.Proceedings of the National Academy of Sciences, 1983
- VARIABLE 5-METHYLCYTOSINE LEVELS IN HUMAN-TUMOR CELL-LINES AND FRESH PEDIATRIC TUMOR EXPLANTS1983
- Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.The Journal of Experimental Medicine, 1982
- Induction of thymidine kinase in enzyme-deficient chinese hamster cellsCell, 1982
- Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor.Proceedings of the National Academy of Sciences, 1982
- Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine.Journal of Biological Chemistry, 1982
- The somatic replication of DNA methylationCell, 1981
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976